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Abstract. Neonatal sepsis is a major cause of morbidities and mortalities mostly remarkable in the 
third world nations.We aimed to assess the value of simultaneous measurement of procalcitonin
(PCT) and interleukin-6 (IL-6) in association with high sensitive
prediction of early neonatal sepsis.
A follow-up study was performed 
clinical  signs  of  sepsis or  maternal  risk  factors  for  sepsis.  Neonates  were  assigned  to  4  groups 
including “proven early-onset sepsis”, “clinical early
“uncertain infectious status”. Blood samples were obtained within the first 12 h of b
between 24 hours and 36 hours of age for determination of serum levels of PCT, IL
white blood cell (WBC) count.
On  admission,  neonates  with  sepsis  had  a  higher  WBC  count,  IL
compared with those neonates without sepsis.  This remained significant even after 12
admission. Also, patients with clinical evidences of sepsis had a higher serum level of PCT and IL
within 12-24 hours after admission compared to the patients with uncertain sepsis.
The combination of PCT and IL-
cutoff value of 8 mg/L) a sensitivity of 82%.The areas under the ROC curve for the two periods 
were 0.801 , and 0.819 respectively.
In final The combination of IL-6,
onset neonatal sepsis.
Introduction.  Neonatal  sepsis  is  a  major  cause  of 
morbidities  and  mortalities  mostly remarkable in  the 
third world nations.
1-3 Early diagnosis and subsequent 
therapy for the infected infants or those with a higher 
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Neonatal sepsis is a major cause of morbidities and mortalities mostly remarkable in the 
We aimed to assess the value of simultaneous measurement of procalcitonin
6) in association with high sensitive- C reactive protein(hs
prediction of early neonatal sepsis.
was performed  on 95 neonates who were below 12 hours (h) of age and
ternal  risk  factors  for  sepsis.  Neonates  were  assigned  to  4  groups 
onset sepsis”, “clinical early-onset sepsis”, “negative infectious status”, and 
“uncertain infectious status”. Blood samples were obtained within the first 12 h of b
between 24 hours and 36 hours of age for determination of serum levels of PCT, IL
On  admission,  neonates  with  sepsis  had  a  higher  WBC  count,  IL-6,  PCT,  and  hs
s without sepsis.  This remained significant even after 12
admission. Also, patients with clinical evidences of sepsis had a higher serum level of PCT and IL
24 hours after admission compared to the patients with uncertain sepsis.
-6 yielded had a sensitivity of 88% and PCT and CRP (using the 
cutoff value of 8 mg/L) a sensitivity of 82%.The areas under the ROC curve for the two periods 
were 0.801 , and 0.819 respectively.
6, hs-CRP, and PCT seems to be predictive in diagnosis of early 
Neonatal  sepsis  is  a  major  cause  of 
remarkable in  the 
Early diagnosis and subsequent 
therapy for the infected infants or those with a higher 
risk may play a vital role in lowering such mortality 
and morbidity rates.
4 Neonatal sepsis has been divided 
into two main categories including early
72 hours of age) and late-onset (after 72 hours of age) 
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Neonatal sepsis is a major cause of morbidities and mortalities mostly remarkable in the 
We aimed to assess the value of simultaneous measurement of procalcitonin
C reactive protein(hs-CRP) in 
were below 12 hours (h) of age and had 
ternal  risk  factors  for  sepsis.  Neonates  were  assigned  to  4  groups 
onset sepsis”, “negative infectious status”, and 
“uncertain infectious status”. Blood samples were obtained within the first 12 h of birth repeated 
between 24 hours and 36 hours of age for determination of serum levels of PCT, IL-6, hs-CRP, and 
6,  PCT,  and  hs-CRP  levels 
s without sepsis.  This remained significant even after 12-24 hours of 
admission. Also, patients with clinical evidences of sepsis had a higher serum level of PCT and IL-6 
24 hours after admission compared to the patients with uncertain sepsis.
6 yielded had a sensitivity of 88% and PCT and CRP (using the 
cutoff value of 8 mg/L) a sensitivity of 82%.The areas under the ROC curve for the two periods 
CRP, and PCT seems to be predictive in diagnosis of early 
risk may play a vital role in lowering such mortality 
Neonatal sepsis has been divided 
egories including early-onset (within 
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sepsis.
1,3,5-7 Unfortunately  signs  and  symptoms  of 
early-onset neonatal sepsis such as respiratory distress 
and  irritability  are  vague  and  not  confined  to  the 
diseases;
8 other  non- infectious  processes  also  may 
present with the same manifestations.
4,7,9Conventional 
methods for diagnosis of sepsis lack enough sensitivity 
and  specificity.
10A  positive  blood  culture  would  be 
reflective  of  an  asymptomatic  underlying  bacteremia 
with  less  concern  while  a  negative  result  for  blood 
culture may not assure lack of infection.
11
The outcome of sepsis in neonates is directly related 
to  the  early  management  of  the  disease,  and  hence 
prompt use of proper antibiotic therapy is absolutely 
essential.
12 However,  in  order  to  prevent  microbial 
resistance  induced  by  unnecessary  administration  of 
empiric therapies and avoiding overwhelmed hospital 
admissions,  a  definite  diagnosis  should  be  secured 
based  on  the  laboratory  tests  with  higher  diagnostic 
value.
2,9-11,13
Procalcitonin  (PCT),  one  of  the  precursors  of 
calcitonin, is a 116 amino acid peptide. Being produced 
by an unknown source (it may be produce in the liver 
or  by  macrophages),  it  is  secreted  into  the  blood 
circulation  during  infection  without  increasing 
calcitonin.
14 PCT is detectable in the plasma as early as 
2 h after the exposure to the bacterial products; its level 
rises for 6 to 8 h, reaches a plateau after 12 h, and then 
decreases to a normal level after 2 to 3 days.
15
Recently PCT has received an important role in the 
diagnosis  of bacterial infection in  both  pediatric  and 
adult  population;  however,  its  accuracy  in  neonatal 
early-onset sepsis is still an issue of controversy.
14,16  
Acute phase reactants and interleukins are also used in 
the  diagnosis  of  bacterial  infection  in  the  neonates. 
Among  these,  interleukin-6  (IL-6)  is  the  most  well 
known marker.
17-20
Direct  measurement  of  serum  level  of  cytokines 
could make the earlier detection of infection possible 
compared to the measurement of acute-phase reactants 
which  in  turn  are  secreted  in  response  to  the 
proinflammatory cytokines. Hence  our study aimed to 
assess the value of simultaneous measurement of PCT 
and IL-6 along with the white blood cell, neutrophil 
and lymphocyte count, blood culture and high sensitive 
C- reactive  protein  (hs-CRP)  in  neonate  populations 
with  a rapid diagnosis of the infection. 
Methods.  A  prospective  cross  sectional  study  was 
conducted among newborns admitted to the  neonatal 
intensive  care  unit  (NICU)  of  Vali-e-Asr  hospital 
affiliated  to  Tehran  University  of  Medical  Sciences 
(TUMS)  in  Tehran,  Iran,  between  January  2009  to 
January  2010.  Newborns  were  considered  eligible  if 
they  met  the  following  inclusion  criteria:  age  was 
below 12 h, they had clinical signs of sepsis, or there 
was  a  maternal risk factor  for  sepsis.  Neonates  with 
congenital malformations and TORCH infection were 
excluded from study.
Clinical signs were considered positive if three or 
more  of  the  following features  were  present:  1. 
respiratory  manifestations  (Apnea  is  a  term  for 
suspension of external breathing. During apnea there is 
no movement  of the  muscles of respiration  and the 
volume of the lungs initially remains unchanged,apnea 
for  at  least  10  seconds,  tachypnea  defined  as 
respiratory rate over 70 / min in preterm and over 60 / 
min  in  term  neonates),  nasal  flaring,  retractions, 
cyanosis,  or  respiratory  distress);  2.  bradycardia 
defined  as  heart  rate  less  than  100  beats  /  min  in 
preterm and less than 80 beats /min in term neonates or 
tachycardia (The upper threshold of heart rate based on 
age :1-2 days:>159 beats per minutes ,bpm, ,3-6 days 
:>166  bpm,1-3  weeks  :>182  bpm,1-2  months  :>179 
bpm) ; 3. hypotonia or seizures; 4. poor skin color or 
capillary  filling  time  >2  s;  and  5.  Irritability  or 
lethargy.
Informed consent was obtained from the parents of 
the neonates for entering the study and the research and 
ethic  committee  of  the  TUMS  approved  the  study 
protocol. 
Sampling.  Blood  samples  were  obtained  by  arterial 
canula within the first 12 h and then repeated between 
24 h and 36 h of age. Samples were centrifuged within 
30 minutes of collection while the serum stored at -20 
◦C  before  analysis  for  determination  of  PCT,  IL-6, 
CRP. CBC differentiation was measured using Sysmex 
XT-1800 cell  counter, Japan;  IL-6  measurement  was 
also performed using a quantitative sandwich enzyme-
linked  immunoassay  technique  (Human  IL-6 
immunoassay, Bioscience, Austria while hs-CRP was 
assessed by a two-site enzyme-linked immunosorbent 
assay  (Elisa) (biosystem,  Barcelona,  Spain).  PCT 
measurement  was  performed  using  a 
immunochromatografic test (Brahms, German).  
Infection  detection.  Based  on  criteria  of  Center  for 
Disease  Control  (CDC)  for  diagnosis  of  neonatal 
sepsis, our patients were selected as following: having 
postnatal signs of sepsis and a positive blood culture 
sampled from peripheral or central venous lines (21).  
Neonates  were  assigned  to  4  groups  including 
proven  early-onset  sepsis,  clinical  early-onset  sepsis, 
negative  infectious  status,  and  uncertain  infectious 
status.  Neonates  with  positive  blood  culture  were 
classified  as “proven early-onset  sepsis” or “positive 
blood  culture  sepsis”.  Neonates  with  negative  blood 
culture, who had positive clinical signs of sepsis (3 or 
more  of  5  aforementioned  categories),  and  positive 
sepsis  screen  (based  on  band  cells  >  20%, Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
polymorphocytosis,  ESR>  55  mm,  suggestive  CSF 
analysis,  and  positive  history  of  chorioamnionitis  or 
PROM) or a maternal risk factors  were classified as 
“clinical  early-onset  sepsis”.  “Negative  infectious 
status  group”  included  neonates  with  negative  blood 
culture  and  negative  sepsis  screen.  Neonates  with 
negative  blood  culture  who  had  only  one  or  no 
abnormal value of the sepsis screening test and fewer 
than three clinical signs of infection were classified as 
“uncertain  infectious  status”.  All  the  cases  proved 
clinically or by culture to be blood positive underwent 
intravenous antibiotic therapy. In addition, appropriate 
care was delivered in neonatal intensive care unit (n-
ICU) in case of general condition's instability. 
Statistical Analysis.  The statistical package SPSS 17 
for  windows  (Chicago,  Illinois,  USA),  was  used  for 
analysis.
After descriptive analysis in the case of non-normal 
data,  the  Kruskal–Wallis  test  was  used  instead. 
Variance homogeneity was checked with the Levene 
test.
The  reliability  of  analytes  concentration  for  the 
diagnosis  of  sepsis  was  calculated  by receiver-
operating characteristics (ROC) curves. Youden's index 
(sensitivity  +  specificity  - 1)  was  used  for 
determination  of  optimal  cutoff  values  of  the 
diagnostic  tests  in  the different  postnatal  periods. 
Sensitivity,  specificity,  and  the  likelihood  ratio  of 
positive  and  negative results  with  a  95%  confidence 
interval  (CI)  were  calculated.  Statistical significance 
was set at P < 0.05.Variables are presented as mean ± 
standard  error  of  mean  (SEM).  For  comparison  of 
serum PCT,  IL- 6,  and  hs-CRP between  the  groups, 
one  way  analysis  of  variance  (ANOVA)  were 
employed followed by post hoc tests.  
Results. Of ninety five neonates who were included in 
our  study,  62  were  female  (65.3%)  and  33  (34.7%) 
were  male.  Mean±  SD  age  of  the  patients  was 
6.59±0.34 h; mean± SD of weight was 3106.58±65.193 
grams among our patients. Cesarean section rate was 
61.1% in our study. In addition, 25(26.3%) of mothers 
were reported to have a fever while 9 (9.4%) of them 
were  diagnosed  as  preeclampsia.  In  6  (6.3%)  of  the 
cases, premature rupture of membrane had occurred. 
Primary  characteristics  of  the  patients  along  with 
clinical  signs of  the  sepsis  are  presented in  table  1. 
There were 79 neonates with sepsis i.e. 30 uncertain, 
30  positive  blood  culture,  and  19  clinical  cases  of 
sepsis, while 16 neonates had no sepsis. Mean age of 
the neonates in each group did not differ significantly 
(p> 0.05).
On  admission,  neonates  with  sepsis  (uncertain 
sepsis,  clinical  sepsis,  and  positive  blood  culture 
sepsis)  had  a  significantly  higher  WBC  count,  and 
serum  levels  of  IL-6,  PCT,  and  hs-CRP  than  those 
neonates  without  sepsis  (p<  0.01).    This  remained 
significant even after 12-24 hours of admission (Table 
2). 
Patients with clinical evidence of sepsis had a 
Table 1: The primary characteristics of the participants
Age(hours) 6.59±0.34
Weight(g) 3106.58±65.193
Head circumference (cm) 34.96±0.136
Apgar Score 
on 5 5(5.3%)
Admission 6 9(9.5%)
7 13(13.7%)
8 44(46.3%)
9 24(25.3%)
Route of 
Delivery
Cesarean Section 58(61.1%)
Vaginal Delivery 37(38.9%)
Gestational 
age
32 6(6.3%)
33 6(6.3%)
34 5(5.3%)
35 18(18.9%)
36 18(18.9%)
37 30(3.6%)
38 12(12.6%)
Apnea 6(6.3%)
Tachypnea 23(24.2%)
Tachycardia 18(18.9%)
Hypotonia 35(36.8%)
Seizure 5 (5.3%)
Lethargy 20(21.2%)
Hypersensitivity 29(30.5%)
Nasal Flaring 8(8.4%)
Poor Skin Color 12(12.6%)
Premature rupture of the membrane 6(6.3%)
Cyanosis 8(8.4%)
Distress 47(49.5%)
Bradycardia 2(2.1%)
Capillary Filling 25(26.3%)
Jaundice 25(26.3%)
Maternal Fever 25(26.3%)
Preeclampsia 9 (9.4%)Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table 2. Comparing the data of the patients with uncertain sepsis, clinical sepsis, blood culture positive sepsis and controls.
Variables are expressed as Mean ± Standard error of mean (SEM). Variable are compared using student t test. *: P<0.05, **: P<0.01, when 
comparing neonates with uncertain sepsis vs. neonates with clinical sepsis and comparing neonates with uncertain sepsis vs. neonates with 
blood culture positive sepsis. The column “p value” is presented, when comparing neonates with blood culture positive sepsis with controls. 
Hs-CRP, high sensitive- C reactive protein, PCT: procalcitonin; NS: not significant.
significantly higher serum level of IL-6 compared to 
the  patients  with  uncertain  sepsis  at  the  time  of 
admission (p< 0.05). They had a higher serum level of 
PCT and  IL-6  on  12-24 hours  after  admission  when 
compared to the patients with uncertain sepsis. Patients 
with  positive  blood  culture  sepsis  had  also  higher 
values of IL-6 compared to the patients with clinical 
sepsis at the time of admission.
The  correlation  coefficients  between  studied 
variables in the different groups are as follows: serum 
levels of PCT were significantly correlated with serum 
levels of IL-6 in patients with no sepsis (r=0.52, p < 
0.05) and uncertain sepsis (r=0.34, p<0.05). However, 
there  were  not  any  significant  correlation  between 
serum levels of IL-6 and PCT in patients with clinical 
sepsis (r=0.03, p=0.5) and positive blood culture sepsis 
(r=0.07, p=0.65). Hs-CRP was significantly correlated 
with PCT in patients with positive blood culture sepsis 
(r=0.54, p<0.001), 12-24 hours after admission.  
The  sensitivity,  specificity,  positive  and  negative 
predictive values of the diagnostic tests within 12 h of 
life at different cut-off values are listed in Table 3. 
The  combination  of  PCT  and  IL-6  yielded  a 
sensitivity of 88%, the combination of PCT and CRP 
(using the cutoff value of 8 mg/L) a sensitivity of 82%, 
neither  combination  being  significantly  higher  than 
with PCT alone. Sensitivity of PCT (76%) compared 
with that of CRP (48%) was significantly (p = 0.011)
different.
We  elaborated  ROC  curves  considering  infected 
and non-infected. The areas under the ROC curve for 
the two periods were 0.801(95% CI, 0.734 to 0.868), 
and  0.819(95%  CI,  0.749  to  0.890),  respectively.
Cutoff levels with the optimum diagnostic efficiency 
derived from the ROC curves were ≥ 4.7 ng/mL at 12–
24 h of life (sensitivity 72.8%, specificity 80.4%), and 
≥  1.7  ng/mL  at  36–48h  of  life  (sensitivity  76.6%, 
specificity 78.2%). 
Discussion. Procalcitonin is an acute phase protein and 
in close correlation with IL-6, TNF- α, and CRP and
Table  3: Sensitivity, specificity, positive (PPV) and negative predictive value (NPV) of 12-h values of procalcitonin, interleukin-6 and hs-
CRP,determined by ROC analysis using the Youden’s index for optimal cut-off values in  neonates with blood-culture-positive and clinical 
sepsis compared to  neonates with negative infectious status.
Diagnostic test Cut-off Sensitivity (%) Specificity (%) PPV (%) NPV (%) Youden
Procalcitonin(ng/ml)
≥1.7 76.6 78.2 93 72 0.684
≥4.7 72 80.4 76 70 0.437
Interleukin-6(pg/ml)
≥60 54 100 100 59 0.543
≥10 71 65 76 60 0.366
≥150 46 100 100 55 0.457
hs-C-reactive protein(mg/L)
≥2.5 69 96 96 67 0.642
≥8 49 100 100 58 0.486Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
increases remarkably early after inflammation.
22-24CRP 
has been used as a diagnostic marker of sepsis for years 
until IL-6 added to its accuracy by providing a double 
combination.
22,25 Several  studies  have  showed 
controversies regarding the ideal marker; Døllner et al. 
have showed that IL-6 and CRP combination are better 
diagnostic parameters compared to other inflammatory 
phase  reactants  including  p55,  p75,  ICAM-1  and  E-
selectin.
25 In  nosocomial  neonatal  sepsis,  PCT  has
received variable accuracy as a diagnostic biomarker. 
Auriti  et  al.  have  reported  an  increased  diagnostic 
accuracy for PCT in neonates with birth weight lower 
than 1500 grams;
26 while López Sastre et al. concluded 
from one hundred infants that PCT is not sufficiently a 
sole  marker  of  nosocomial  neonatal  sepsis  and  this 
would  be  a  part  of  full  sepsis  evaluation.
13
Simultaneous  measurement  of  serum  markers  in 
diagnosis of early onset neonatal infection have also 
been suggested by combination of IL-8 and CRP by 
Frnaz et al.
27        
Our study aimed to determine if procalcitonin could 
add to the predictive values of other serum biomarkers 
when approaching to the neonatal sepsis by performing 
a  diagnostic  combination  for  sepsis.  The  diagnostic 
benefits  of  PCT  in  diagnosis  of  sepsis  have  been 
widely investigated in the studies.
28,29 However, it has 
been  cautioned  that  this  could  not  serve  as  a  sole
marker in detection of neonatal sepsis and should be a 
part of a full sepsis work up.
13
The main problem with PCT as a diagnostic tool in 
neonates is the physiological increase over the first 48 
h of life and we must differentiated it from infection.
Our results showed that WBC, IL-6, hs-CRP, and 
PCT values were higher among neonates with sepsis 
compared with those without sepsis either at the time 
of admission or at the end of the first day of life. Sever 
inflammatory response is what the studies point to as 
an important cause for increased level of IL-6, hs-CRP, 
PCT, and WBC.
8, 13-15, 17-19, 25, 29-30 There is no doubt that 
inflammatory  biomarkers  are  elevated  in  neonatal 
sepsis  but  there  are  controversies  if  some  of  these 
combinations  could  play a faster role in  an  earlier 
onset  phase.  WBC  has  been  reported  to  be  of  less 
diagnostic  value  in  neonatal  sepsis.
31 CRP  is  also 
believed to elevate during other inflammatory process 
and does not provide an efficient specificity in neonatal 
sepsis;
22 this however does not include PCT and hence 
it seems that PCT would find its way among diagnostic 
markers soon either in a solo
22 or combinative setting.
25
In  our  study,  IL-6  was  higher  in  patients  with 
clinical evidences of sepsis and even higher in those 
with a positive blood culture. Evidences confirm that 
IL-6 levels increase rapidly after exposure to bacterial
components.
8, 29, 31A very short half life of IL-6 makes 
it undetectable in 24 hours after the onset of illness; so 
a specificity and sensitivity of 89%, 67%, 58 % passes 
in 0, 24, and 48 hours of neonatal sepsis, respectively.
22
It seems that while there are infective particles in the 
blood,  IL-6 could  be detected in  order to secure the 
diagnosis of sepsis.   
In  our  study,  PCT  was  also  higher  in  clinically 
proven sepsis patient compared to cases of uncertain 
sepsis; PCT begins to increase in 2 h of sepsis onset 
and precedes the increased level of IL-6 and CRP.
15,30
Besides, in younger children, the diagnostic value of 
PCT even is higher in comparison to other infectious 
markers  such  as  CRP  and  IL-6.
28 In  neonates,  PCT 
continues to rise within first 48 hours of life
15, 27, 29 and 
even  its  level  is  also  impressed  by  non  infectious 
conditions  including  asphyxia,  hypoxemia,  and 
intracranial hemorrhage.
15
IL-6  serum  level  was  shown  to  be  correlated 
directly with levels of PCT in the patients of uncertain 
sepsis and without sepsis in our population; however, 
this  was  not  significantly  different  between  another 
two  groups  of  clinical  and  positive  blood  culture 
sepsis. IL-6 although rises sharply after exposure to the 
bacterial  products, falls  rapidly  as  time  elapse  and 
become undetectable in 24 hours.
20,21. In contrast, PCT 
begins to rise within this duration and this may cause 
the separation of serum levels of these markers despite 
the  correlation  which  is  seen  among  individuals 
without sepsis or of uncertain sepsis.         
Our results demonstrate that hs-CRP play a role in 
the  early  diagnosis  of  neonatal  sepsis  when  cut-off 
values are lowered, according to the results of the ROC 
analysis.
Our study showed that hs- CRP was correlated with 
the levels of PCT in positive blood culture sepsis after 
12-24  h  of  admission.  In  contrast  to  the  narrow 
diagnostic  window  of  IL-6,  CRP  is  capable  to  be 
diagnostic in later time after the initiation of infection 
or its symptoms.
26 It seems that both PCT and hs- CRP 
are late markers which would improve the diagnostic 
probability in clinical setting. This may be the reason 
why these two markers are correlated in neonates with 
proven  blood  infections  in  a  late  time  i.e.  12  to  24 
hours after admission. 
According  to  the  study’s  findings,  simultaneous 
measurement  of  PCT,  IL-6  and  hs-CRP    is  more 
sensitive in  diagnosis  of  neonate    infections.  Our 
results are similar to some other studies.
21,23-5 Hence, 
simultaneous  measurement  of  these  tests  is 
recommended for infection diagnosis.   
The main limitation of our study is its short term 
duration  of  follow  up  both to  secure  a  prognostic 
estimation  and face  later  clinical  and  laboratory 
challenges; however we took advantage of a relatively 
large sample size and close similarity between groups 
in  most  of  the  potentially  confounding  variables.  In Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
order to reach  a consistent similarity between studies’ 
results,  we need  a  widely  acceptable  definition  for 
sepsis  so we based  upon  CDC  criteria.  Besides, 
prenatology  and  gestational  histories  also  should  be 
taken  into  consideration  to  resolve  varieties  behind 
causes of sepsis. Higher rate of cesarean section (CS) 
in our study (61.1%) in comparison to other societies 
could  be  due  to  the  increasing  incidence  of  section 
within  the  last  years.
22-25 Although  in  developed 
countries this has occurred with a slower pace, in low 
income  nations,  it  could  be  experienced  by  a  much 
more ascending steep.
22 Also in our country of Iran, the 
overall rate of CS has been showed to be 85.3% 
22 of 
which most occurs as a result of repeated section. This 
however was not associated with an interfering effect 
as  the  rate  of  section  did  not  differ  significantly 
between the four assigned groups. In order to define 
the  most  proper serum  marker  to  diagnose  neonatal 
sepsis on time, one should obtain sufficient sensitivity 
and specificity; besides, it should be detectable based 
on the defined cut offs either in an early phase or at the 
later time. Considering that  no single marker seems to 
provide all the mentioned characteristics , so far all the 
recommendations  are  pointing  to  a  combination  of 
inflammatory markers as a part of diagnostic work up 
for  neonatal  sepsis.  These  combinative  diagnostic 
approaches should receive more evidence to be widely 
applicable in clinical practice.  
Conclusion. We showed a higher serum level of PCT, 
hs-CRP, and IL-6 in neonates with sepsis compared to 
those  without  sepsis.  However,  due  to  the  lack  of 
consensus in  definition of sepsis  and  because of the 
heterogeneity in the statistics of our studies just as in
the  others’  studies,  attention  should  be  paid  in 
interpreting  the results. This study paves the road for 
future studies in determining  sensitivity and specificity 
of diagnostic tests in early phases of neonatal sepsis.  
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